Beclobrate

CHEMBL152684 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
346.8 g/mol
LogP
5.8
Phase
4

A fibrate-class lipid-lowering agent that reduces triglycerides and raises HDL cholesterol by activating PPAR-alpha receptors in the liver to alter fat metabolism.

Peso molecular

346,8000 g/mol

LogP

5,80

TPSA

35,50 Ų

Regla de cinco de Lipinski

Cumple

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOC(=O)C(C)(CC)Oc1ccc(Cc2ccc(Cl)cc2)cc1

InChI

InChI=1S/C20H23ClO3/c1-4-20(3,19(22)23-5-2)24-18-12-8-16(9-13-18)14-15-6-10-17(21)11-7-15/h6-13H,4-5,14H2,1-3H3

Molecular Formula

C20H23ClO3

HBD / HBA

- / 3

Enlaces Rotables

8

Átomos Pesados

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A fibrate-class lipid-lowering agent that reduces triglycerides and raises HDL cholesterol by activating PPAR-alpha receptors in the liver to alter fat metabolism.

Yes, Beclobrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL152684. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 51348. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.